Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 70%
Hold 10%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT is well-positioned due to its strong position in the healthcare-related real estate market and its three operating platforms in SNFs, SHOP, and UK care homes. The company is expected to drive incremental growth through its investments in these sectors while also maintaining a low leverage profile. Additionally, CTRE's decision to diversify into new asset classes and its superior operator mix coming out of the pandemic make it an attractive investment opportunity for investors seeking growth.

Bears say

CareTrust REIT is facing multiple risks that could have a negative impact on its profitability. These include an unpredictable regulatory environment, potential issues with new tenants, and a competitive investment market. Furthermore, there is a risk that the company's acquisitions may not generate the expected return and there is a high concentration of revenue from one tenant, Ensign. Considering these risks, coupled with the involvement in the healthcare sector that is subject to complex regulations, there is a possibility of limited investment opportunities and increased market competition which could impact the company's profitability and valuation.

CareTrust REIT (CTRE) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 70% recommend Buy, 10% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 10 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Jun 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.